Bitolterol mesylate: a beta-adrenergic agent. Chemistry, pharmacokinetics, pharmacodynamics, adverse effects and clinical efficacy in asthma
- PMID: 3895171
- DOI: 10.1002/j.1875-9114.1985.tb03410.x
Bitolterol mesylate: a beta-adrenergic agent. Chemistry, pharmacokinetics, pharmacodynamics, adverse effects and clinical efficacy in asthma
Abstract
Bitolterol, (3-4 diester colterol) is a new beta 2-adrenergic agonist. Since it in itself is biologically inactive, bitolterol is considered a pro-drug. When administered it is activated within the lung by esterase hydrolysis to the active compound colterol catecholamine N-t-butyl-arterenol). In preclinical and clinical studies to date, bitolterol has proved to be an effective bronchodilator for adult and pediatric patients with chronic stable asthma and for some with chronic obstructive pulmonary disease. Bitolterol has been compared with other beta 2 agents, including isoproterenol, metaproterenol and albuterol. There is no evidence for cardiotoxicity when bitolterol is used in combination with theophylline in human studies. It is effective for control of exercise-induced asthma.
Similar articles
-
Bitolterol. A preliminary review of its pharmacological properties and therapeutic efficacy in reversible obstructive airways disease.Drugs. 1988 Jan;35(1):22-41. doi: 10.2165/00003495-198835010-00002. Drugs. 1988. PMID: 3278878 Review.
-
New beta 2-adrenergic agonist aerosols.Clin Pharm. 1985 Jul-Aug;4(4):393-403. Clin Pharm. 1985. PMID: 2864159 Review.
-
Dose-response study of nebulized bitolterol mesylate solution in asthmatic patients.Chest. 1987 Apr;91(4):533-9. doi: 10.1378/chest.91.4.533. Chest. 1987. PMID: 3549173 Clinical Trial.
-
Bitolterol and albuterol metered-dose aerosols: comparison of two long-acting beta 2-adrenergic bronchodilators for treatment of asthma.J Allergy Clin Immunol. 1985 Jan;75(1 Pt 1):55-62. doi: 10.1016/0091-6749(85)90012-0. J Allergy Clin Immunol. 1985. PMID: 3968329 Clinical Trial.
-
Bitolterol mesylate in exercise-induced asthma.J Allergy Clin Immunol. 1986 Jan;77(1 Pt 1):32-6. doi: 10.1016/0091-6749(86)90318-0. J Allergy Clin Immunol. 1986. PMID: 3944373 Clinical Trial.
Cited by
-
Asthma and COPD: A Focus on β-Agonists - Past, Present and Future.Handb Exp Pharmacol. 2024;285:369-451. doi: 10.1007/164_2023_679. Handb Exp Pharmacol. 2024. PMID: 37709918 Review.
-
Bitolterol. A preliminary review of its pharmacological properties and therapeutic efficacy in reversible obstructive airways disease.Drugs. 1988 Jan;35(1):22-41. doi: 10.2165/00003495-198835010-00002. Drugs. 1988. PMID: 3278878 Review.
-
Adverse reactions to beta 2-agonist bronchodilators.Med Toxicol. 1986 Jul-Aug;1(4):286-99. doi: 10.1007/BF03259844. Med Toxicol. 1986. PMID: 2878344 Review.
-
Clinical pharmacokinetics of beta-agonists.Clin Pharmacokinet. 1990 Apr;18(4):270-94. doi: 10.2165/00003088-199018040-00002. Clin Pharmacokinet. 1990. PMID: 1969785 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical